What Know About This Fund’s Exit From Ascendis Pharma
A notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Explore common reasons budgets fail and practical fixes you can apply now to improve accuracy, discipline, and long-term results.
20,131 articlesA notable fund liquidated its entire Ascendis Pharma stake, signaling a strategic rotation in a volatile biotech sect...
Two lesser-known mining names outside China are surging as Pentagon demand and Western reshoring reshape the rare ear...
A sharp move in bicara stock 50% has spotlighted a bold biotech bet that now accounts for nearly a third of one inves...
Entering a competitive housing market? Don’t risk losing a deal. This guide walks you through 10 essential loan-ready...
Investors are weighing Alibaba's AI and cloud ambitions against profits and regulatory headwinds. This guide breaks d...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Fluence Energy surged nearly 100% in a week on big contract wins and a growing backlog. A quartet of AI-exposed energ...
Investor sentiment shifted on a day when Poet Technologies announced a large equity offering. This piece explains wha...
As Target prepares for its Q1 2026 earnings call, savvy investors want clarity on sales growth, margins, and the path...
Bitwise argues that investors have not fully priced Hyperliquid's expansion into a multi-asset platform and the value...
Two of Washington’s most watched political figures disclosed stakes in Vistra, a mid-size energy player poised as AI ...
Silver surged and fell in a wild year, turning SLV into a headline idea for investors. This guide walks through what ...